Automated detection of focal seizures using subcutaneously implanted electrocardiographic device: A proof‐of‐concept study
Epilepsia · 2023-12 · 64 (S4)
DOI: 10.1111/epi.17612 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, online erschienen am 08.05.2023. Verfasst von Jesper Jeppesen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurophysiology, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Electroencephalography, Wearable Electronic Devices. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Det Frie Forskningsråd, Danmarks Frie Forskningsfond.
Abstract (Originalsprache)
Phase 2 studies showed that focal seizures could be detected by algorithms using heart rate variability (HRV) in patients with marked autonomic ictal changes. However, wearable surface electrocardiographic (ECG) devices use electrode patches that need to be changed often and may cause skin irritation. We report the first study of automated seizure detection using a subcutaneously implantable cardiac monitor (ICM; Confirm Rx, Abbott). For this proof‐of‐concept (phase 1) study, we recruited six patients admitted to long‐term video‐electroencephalographic monitoring. Fifteen‐minute epochs of ECG signals were saved for each seizure and for control (nonseizure) epochs in the epilepsy monitoring unit (EMU) and in the patients' home environment (1–8 months). We analyzed the ICM signals offline, using a previously developed HRV algorithm. Thirteen seizures were recorded in the EMU, and 41 seizures were recorded in the home‐monitoring period. The algorithm accurately identified 50 of 54 focal seizures (sensitivity = 92.6%, 95% confidence interval [CI] = 85.6%–99.6%). Twelve of the 13 seizures in the EMU were detected (sensitivity = 92.3%, 95% CI = 77.2%–100%), and 38 of the 41 seizures in the out‐of‐hospital setting were detected (sensitivity = 92.7%, 95% CI = 84.7%–100%). Four false detections were found in the 141 control (nonseizure) epochs (false alarm rate = 2.7/24 h). Our results suggest that automated seizure detection using a long‐term, subcutaneous ICM device is feasible and accurate in patients with focal seizures and autonomic ictal changes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Neurophysiology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Neurophysiology, Danish Epilepsy Center, Dianalund, Denmark.
ORCID-Profile: Jesper Jeppesen, Jakob Christensen, Sándor Beniczky
Förderung
- Det Frie Forskningsråd
- Danmarks Frie Forskningsfond
Zitieren
APA
Jeppesen, J., Christensen, J., Mølgaard, H., & Beniczky, S. (2023). Automated detection of focal seizures using subcutaneously implanted electrocardiographic device: A proof‐of‐concept study. Epilepsia, 64(S4). https://doi.org/10.1111/epi.17612
Vancouver
Jeppesen J, Christensen J, Mølgaard H, Beniczky S. Automated detection of focal seizures using subcutaneously implanted electrocardiographic device: A proof‐of‐concept study. Epilepsia. 2023;64(S4). doi:10.1111/epi.17612
BibTeX
@article{Jeppesen2023,
author = {Jeppesen, Jesper and Christensen, Jakob and Mølgaard, Henning and Beniczky, Sándor},
title = {Automated detection of focal seizures using subcutaneously implanted electrocardiographic device: A proof‐of‐concept study},
journal = {Epilepsia},
year = {2023},
volume = {64},
number = {S4},
doi = {10.1111/epi.17612}
}
EUVIMED